← FDA DRUG APPROVALS

FDA ANDA · ANDA074077

LACTULOSE

Sponsor: PAI HOLDINGS PHARM

APPLICATION
ANDA074077
TYPE
ANDA
ORIGINAL APPROVAL
1995-07-03
LATEST ACTION
2009-09-04
ROUTE
ORAL, RECTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LACTULOSEDiscontinued
LACTULOSE 10GM/15ML · SOLUTION · ORAL, RECTAL

Approval history

2009-09-04Labeling · Supplement 7AP
2009-05-05Labeling · Supplement 5AP
1997-10-09Manufacturing (CMC) · Supplement 2AP
1997-10-09Manufacturing (CMC) · Supplement 3AP
1997-10-09Manufacturing (CMC) · Supplement 1AP
1995-07-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →